The Monsanto Roundup Lawsuit claims that exposure to Roundup Weed Killer causes Non-Hodgkin Lymphoma and other health problems, and manufacturers of the chemical failed to warn consumers of this potential risk.
Roundup is a popular herbicide that is used by farmers, gardeners, and homeowners to control weeds.
The active ingredient in Roundup is glyphosate, which has been classified as a probable human carcinogen by the International Agency for Research on Cancer (IARC).
There is evidence to suggest that exposure to Roundup may increase the risk of developing non-Hodgkin lymphoma, a type of cancer that affects the lymphatic system.
Monsanto, now a subsidiary of Bayer, has faced numerous lawsuits linking Roundup to cancer and about the the safety of its Roundup products:
- In August 2018, a jury in San Francisco awarded $289 million to a groundskeeper who claimed that his non-Hodgkin lymphoma was caused by exposure to Roundup. This verdict was later reduced to $78.5 million, and Monsanto appealed the decision.
- In March 2019, another jury in California awarded $80 million to a man who claimed that his non-Hodgkin lymphoma was caused by exposure to Roundup. Monsanto has appealed this decision as well.
It is important to note that non-Hodgkin lymphoma is not the only potential injury that has been linked to Roundup.
Other potential injuries that have been reported in individuals who have been exposed to Roundup include:
- Cancer of the thyroid, pancreas, prostate, and liver
- Skin irritation and rashes
- Eye irritation and blurred vision
- Respiratory problems
If you or a loved one has suffered from any of these injuries or other adverse effects after being exposed to Roundup weed killer, it’s important to speak with an experienced attorney to understand your legal options.
Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a Roundup claim instantly.
Supreme Court Declined Appeal from BayernAG to Block Roundup Cancer Lawsuits
In June 2022, the US Supreme Court refused to block Roundup lawsuits and upheld a $25 million verdict for a case filed by a California resident.
Bayer responded by saying it “respectfully disagrees” with the Supreme Court decision and that the company is “fully prepared to manage the litigation risk associated with potential future claims in the U.S.”